Patents by Inventor Mark Von Itzstein

Mark Von Itzstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral agents and uses thereof
    Patent number: 12590092
    Abstract: The present invention relates to a compound of Formula (I), or a pharmaceutically acceptable salt thereof: and to pharmaceutical compositions comprising the compound. In Formula (I), R3 is selected from the group consisting of: wherein rings W, X, Y and Z may relate to various heterocyclic, heteroaryl, cycloalkyl, cycloalkenyl, and/or aryl rings. The present invention also relates to uses of the compounds in treating a disease, disorder or condition caused by viral infection.
    Type: Grant
    Filed: January 28, 2022
    Date of Patent: March 31, 2026
    Assignee: GRIFFITH UNIVERSITY
    Inventors: Mark Von Itzstein, Ibrahim El-Deeb, Patrice Guillon, Larissa Heilig
  • ANTIVIRAL AGENTS AND USES THEREOF
    Publication number: 20240109886
    Abstract: The present invention relates to a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and to pharmaceutical compositions comprising the compound. In Formula (I), rings W, X, Y and Z may relate to various heterocyclic, heteroaryl, cycloalkyl, cycloalkenyl, and/or aryl rings. The present invention also relates to uses of the compounds in treating a disease, disorder or condition caused by viral infection.
    Type: Application
    Filed: January 28, 2022
    Publication date: April 4, 2024
    Applicant: GRIFFITH UNIVERSITY
    Inventors: Mark VON ITZSTEIN, Ibrahim EL-DEEB, Patrice GUILLON, Larissa HEILIG
  • ANTIVIRAL AGENTS AND USES THEREOF
    Publication number: 20220274965
    Abstract: The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt thereof: Formula (I) In which R3 is selected from the group consisting of optionally substituted N-linked naphthotriazole, optionally substituted N-linked indazole, and certain N-linked triazoles. The present invention also relates to uses of the compounds in treating a disease, disorder or condition caused by viral infection, and pharmaceutical compositions comprising the compounds.
    Type: Application
    Filed: July 30, 2020
    Publication date: September 1, 2022
    Applicant: GRIFFITH UNIVERSITY
    Inventors: Mark Von Itzstein, Ibrahim El-Deeb, Larissa Heilig, Patrice Guillon
  • ZINC IONOPHORES AND USES THEREOF
    Publication number: 20200261440
    Abstract: This invention relates to the use of zinc(II) salts in combination with a zinc ionophore to resensitize a previously resistant pathogenic bacteria to an antibiotic. Methods of restoring the sensitivity of a resistant pathogenic bacterium to an antibiotic comprising administering a zinc ionophore in combination with a zinc(II) salt and methods of treating a bacterial infection comprising administering a zinc ionophore in combination with a zinc (II) salt concurrently and/or sequentially with administration of a therapeutically effective amount of an antibiotic is also described.
    Type: Application
    Filed: October 12, 2018
    Publication date: August 20, 2020
    Inventors: Mark WALKER, Christopher MCDEVITT, Mark VON ITZSTEIN, Alastair MCEWAN
  • Antiviral agents and uses thereof
    Patent number: 10028938
    Abstract: The present invention relates to compounds which are found to exhibit an antiviral effect. The compounds are modulators of the activity of the viral haemagglutinin and/or neuraminidase enzymes.
    Type: Grant
    Filed: September 7, 2015
    Date of Patent: July 24, 2018
    Assignee: Griffith University
    Inventors: Mark Von Itzstein, Ibrahim El-Deeb, Larissa Dirr, Patrice Guillon, Moritz Winger
  • ANTIVIRAL AGENTS AND USES THEREOF
    Publication number: 20170290809
    Abstract: The present invention relates to compounds which are found to exhibit an antiviral effect. The compounds are modulators of the activity of the viral haemagglutinin and/or neuraminidase enzymes.
    Type: Application
    Filed: September 7, 2015
    Publication date: October 12, 2017
    Applicant: Griffith University
    Inventors: Mark Von Itzstein, Ibrahim El-Deeb, Larissa Dirr, Patrice Guillon, Moritz Winger
  • ANTI-INFLUENZA AGENTS
    Publication number: 20120202877
    Abstract: The present invention relates to compounds that selectively inhibit influenza A virus group (1) sialidases and are therefore potential anti-influenza agents.
    Type: Application
    Filed: July 16, 2010
    Publication date: August 9, 2012
    Inventors: Mark Von Itzstein, Jeffrey Clifford Dyason, Robin Thomson, Santosh Rudrawar, Mauro Pascolutti